EU Transdermal Patch: Generic Submission [Design Issues]

posted by HallaGulla – 2023-03-08 09:58 (854 d 01:32 ago) – Posting: # 23491
Views: 2,081

(edited on 2023-03-08 11:11)

Hi All

One of the clients with whom I am working is developing a generic transdermal patch for UK/EU submission.

They are asking us to do the PK study, Adhesion study and skin senstization study in either EU/UK or in USA due to simialr climatic condition.

My question is, can these studies be done in India or any other countries? Does MHRA/EMA accepts transdermal studies done in the geographies which has a different climatic conditions?


TIA...


Edit: Category changed; see also this post #1. Are you really located in Japan? ;-) [Helmut]

:lol: Shhhhh

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,690 registered users;
58 visitors (0 registered, 58 guests [including 14 identified bots]).
Forum time: 12:31 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5